Eventide Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Other funds holding MYOV
BG
NCM
CAM
VA
EP
Eventide Asset Management's MYOV Position: Q2 2020 in Review
Eventide Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q2 2020, closing a stake of 800,000 shares — an estimated $6.04M sold.
Eventide Asset Management first reported a position in MYOV in Q1 2017 and held it in 13 quarters. The position peaked at $64M in Q4 2019. 96 funds tracked by Wall St. Rank hold MYOV as of Q2 2020.
- Eventide Asset Management reported no remaining Myovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
- Eventide Asset Management sold 800,000 Myovant Sciences Ltd. shares in Q2 2020, an estimated $6.04M.
- Eventide Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 13 quarters.
- Eventide Asset Management's Myovant Sciences Ltd. position peaked at $64M in Q4 2019.
- 96 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2020.
Based on Eventide Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.